Tactics without strategy is noise. Content calendars, brand positioning, growth frameworks, product launches, and buyer psychology all share one trait: they work when built on real insight, not templates.
Most marketing strategy fails because it confuses activity with progress. The resources here focus on the thinking behind the doing: how to position, how to prioritise, and how to build plans that survive contact with real markets.
Aruba Networks has built a brand reputation that most B2B technology companies quietly envy but rarely study closely enough. As a Hewlett Packard Enterprise company specialising in networking infrastructure, Aruba has managed to maintain credibility with highly technical buyers while avoiding the brand erosion that typically follows a major acquisition. That is not an accident….
A Mercedes-Benz SWOT analysis reveals a brand sitting at an unusual intersection: one of the most recognised luxury names in automotive history, facing structural cost pressures, an uneven electric vehicle transition, and intensifying competition from brands that didn’t exist fifteen years ago. The strengths are real and deeply embedded. So are the vulnerabilities. This analysis…
B2B brand research is the structured process of understanding how your company is perceived by buyers, prospects, and the market, and using that intelligence to sharpen positioning, messaging, and go-to-market decisions. Done well, it closes the gap between what you think your brand communicates and what the market actually hears. Most B2B companies skip it,…
B2B marketing analytics implementation fails most often not because of the wrong tools, but because of the wrong starting question. Most teams begin by asking “what should we measure?” when they should be asking “what decisions do we actually need to make?” Get that backwards and you end up with dashboards full of numbers that…
A pharmaceutical new product launch checklist is a structured sequence of pre-launch, launch, and post-launch activities covering regulatory clearance, market access, medical affairs alignment, HCP engagement, patient support, and commercial execution. Done well, it prevents the most common failure mode in pharma launches: teams that are technically ready but commercially underprepared. Most pharma launches don’t…
A market entry strategy for a new product is the plan that defines how you bring something to market, who you target first, how you position against existing alternatives, and how you build commercial momentum from a standing start. Done well, it turns a product launch into a growth platform. Done poorly, it burns budget…
Practical marketing intelligence
for people who think.
© 2026 The Marketing Juice